Molecular Pharmacology: 34 (3)

September 01, 1988; Volume 34,Issue 3

You have access
Dihydropyridine Bay K 8644 activates T lymphocyte calcium-permeable channels.
W Young, J Chen, F Jung and P Gardner

Molecular Pharmacology September 1988, 34 (3) 239-244;
You have access
Do canrenone and 6,7-dihydroxylated derivatives compete with ouabain at the same site on Na,K-ATPase?
D M Tal and S J Karlish

Molecular Pharmacology September 1988, 34 (3) 245-249;
You have access
N-methyl-D-aspartate receptor regulation of uncompetitive antagonist binding in rat brain membranes: kinetic analysis.
D W Bonhaus and J O McNamara

Molecular Pharmacology September 1988, 34 (3) 250-255;
You have access
Conversion of 5-hydroperoxyeicosatetraenoic acid into leukotriene B4 by rat hepatocytes: a novel cellular source for leukotriene B4.
J Gut, D W Goldman and J R Trudell

Molecular Pharmacology September 1988, 34 (3) 256-264;
You have access
Smoking-related alterations in epidermal growth factor and insulin receptors in human placenta.
S L Wang, G W Lucier, R B Everson, G I Sunahara and K T Shiverick

Molecular Pharmacology September 1988, 34 (3) 265-271;
You have access
Molecular characterization and mitochondrial density of a recognition site for peripheral-type benzodiazepine ligands.
L Antkiewicz-Michaluk, A Guidotti and K E Krueger

Molecular Pharmacology September 1988, 34 (3) 272-278;
You have access
Mechanism of enhanced sensitivity to bradykinin in pertussis toxin-treated fibroblasts: toxin increases bradykinin-stimulated prostaglandin formation.
J Moss, B E Hom, E L Hewlett, S C Tsai, R Adamik, J L Halpern, S R Price and V C Manganiello

Molecular Pharmacology September 1988, 34 (3) 279-285;
You have access
Interactions of liposome-incorporated amphotericin B with kidney epithelial cell cultures.
H J Krause and R L Juliano

Molecular Pharmacology September 1988, 34 (3) 286-297;
You have access
Excitatory amino acid receptors expressed in Xenopus oocytes: agonist pharmacology.
T A Verdoorn and R Dingledine

Molecular Pharmacology September 1988, 34 (3) 298-307;
You have access
Opiate binding in calf thalamic membranes: a selective mu 1 binding assay.
J A Clark, R Houghten and G W Pasternak

Molecular Pharmacology September 1988, 34 (3) 308-317;
You have access
Subclassification of beta-adrenergic receptors of rat fat cells: a re-evaluation.
S W Bahouth and C C Malbon

Molecular Pharmacology September 1988, 34 (3) 318-326;
You have access
Antibodies to a synthetic peptide can be used to distinguish between muscarinic acetylcholine receptor binding sites in brain and heart.
G R Luthin, J Harkness, R P Artymyshyn and B B Wolfe

Molecular Pharmacology September 1988, 34 (3) 327-333;
You have access
Characterization of agonist radioligand interactions with porcine atrial A1 adenosine receptors.
M Leid, M I Schimerlik and T F Murray

Molecular Pharmacology September 1988, 34 (3) 334-339;
You have access
Evidence for alpha 1-adrenergic receptor internalization in DDT1 MF-2 cells following exposure to agonists plus protein kinase C activators.
M S Cowlen and M L Toews

Molecular Pharmacology September 1988, 34 (3) 340-346;
You have access
The potency and kinetics of the beta-adrenergic receptors on human neutrophils.
H Mueller, H J Motulsky and L A Sklar

Molecular Pharmacology September 1988, 34 (3) 347-353;
You have access
Mechanism of gamma-aminobutyric acid/benzodiazepine receptor turnover in neuronal cells: evidence for nonlysosomal degradation.
L A Borden and D H Farb

Molecular Pharmacology September 1988, 34 (3) 354-362;
You have access
Structure-activity studies of morphine fragments. I. 4-alkyl-4-(m-hydroxy-phenyl)-piperidines.
G H Loew, J A Lawson, E T Uyeno, L Toll, G Frenking, W Polgar, L Y Ma, N Camerman and A Camerman

Molecular Pharmacology September 1988, 34 (3) 363-376;
You have access
Structure-activity relationship of aldose reductase inhibitors based on X-ray crystal structures of oxazolecarbamate derivatives.
T Ishida, Y In, H Ohishi, D Yamamoto, M Inoue, C Tanaka, Y Ueno, Y Ohmomo, N Kanda and A Tanaka

Molecular Pharmacology September 1988, 34 (3) 377-387;
You have access
The effect of oxygen free radicals on calcium permeability and calcium loading at steady state in cardiac sarcoplasmic reticulum.
E Okabe, C Odajima, R Taga, R C Kukreja, M L Hess and H Ito

Molecular Pharmacology September 1988, 34 (3) 388-394;
You have access
Inhibition of glucokinase by alloxan through interaction with SH groups in the sugar-binding site of the enzyme.
S Lenzen, S Freytag and U Panten

Molecular Pharmacology September 1988, 34 (3) 395-400;
You have access
Evidence for a copper:S-(methylthio)-L-homocysteine complex as a glutamine antagonist of cytidine triphosphate synthesis in L1210 murine leukemia cells.
M Rabinovitz and J M Fisher

Molecular Pharmacology September 1988, 34 (3) 401-406;
You have access
Metabolism and excretion of S-conjugates derived from hexachlorobutadiene in the isolated perfused rat kidney.
D Schrenk, W Dekant and D Henschler

Molecular Pharmacology September 1988, 34 (3) 407-412;
You have access
Effect of hypoxia on tert-butylhydroperoxide-induced oxidative injury in hepatocytes.
D L Tribble, D P Jones and D E Edmondson

Molecular Pharmacology September 1988, 34 (3) 413-420;

Main menu

User menu

Search

Table of Contents

In this issue

Navigate

More Information

ASPET's Other Journals